Glioblastoma
Not recruitingStudy on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma
Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma
- Disease:Glioblastoma
- Substances:Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
Germany- Participants:18–64 years · 65+ years
- Substances:Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
- Sponsor:Heinrich-Heine-Universitaet Duesseldorf







